Mild Cognitive Impairment (MCI)
What is Mild Cognitive Impairment (MCI)?
Mild cognitive impairment is a condition where memory or thinking skills decline more than expected for your age. People with MCI notice changes in their mental abilities, but these changes are not severe enough to interfere with daily life. You can still work, drive, manage finances, and live independently.
MCI sits in the space between normal aging and dementia. Not everyone with MCI will develop dementia. Some people with MCI stay stable for years, and others actually improve over time. However, people with MCI have a higher risk of developing Alzheimer's disease or other forms of dementia compared to those without cognitive changes.
Understanding your risk factors early allows you to take action. Lifestyle changes, mental exercises, and medical monitoring can help slow cognitive decline. Testing for genetic markers like ApoE can help predict your likelihood of progression and guide personalized prevention strategies.
Symptoms
- Forgetting recent conversations, appointments, or events more often than before
- Trouble finding the right words during conversations
- Difficulty making decisions or planning complex tasks
- Taking longer to complete familiar mental tasks
- Problems with judgment that are noticeable to family or friends
- Losing items more frequently or putting them in unusual places
- Feeling overwhelmed by decisions or new environments
- Trouble following the flow of conversations or movies
Many people with MCI remain aware of their memory changes, which differs from dementia. Family members and close friends often notice the changes before medical testing confirms them.
Concerned about Mild Cognitive Impairment (MCI)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
MCI results from changes in the brain that affect memory and thinking. The exact cause varies by person. Brain imaging often shows shrinkage in areas responsible for memory, particularly the hippocampus. Abnormal protein deposits, including beta-amyloid plaques and tau tangles, can build up in the brain years before symptoms appear. Reduced blood flow to the brain and inflammation may also contribute to cognitive decline.
Risk factors include advancing age, family history of dementia, carrying the ApoE ε4 gene variant, cardiovascular disease, diabetes, high blood pressure, high cholesterol, smoking, depression, sleep apnea, and lack of mental or physical activity. People who carry one or two copies of the ApoE ε4 gene have significantly higher risk of MCI progressing to Alzheimer's disease. Lifestyle factors like poor diet, social isolation, and head injuries also increase risk.
How it's diagnosed
Doctors diagnose MCI through a combination of medical history, cognitive testing, and physical examination. Your doctor will ask about your memory concerns and how they affect daily activities. Neuropsychological tests measure memory, language, attention, and problem-solving skills. These tests compare your performance to people of similar age and education level.
Blood tests help rule out reversible causes of cognitive decline like thyroid problems, vitamin deficiencies, or infections. Genetic testing for Apolipoprotein E genotype can assess your risk of progression from MCI to Alzheimer's dementia. Rite Aid offers ApoE genotype testing as an add-on to help you understand your genetic risk factors. Brain imaging with MRI or CT scans may be recommended to look for strokes, tumors, or brain shrinkage.
Treatment options
- Regular physical exercise, including both aerobic activity and strength training
- Mediterranean-style diet rich in vegetables, fruits, fish, olive oil, and whole grains
- Mental stimulation through reading, puzzles, learning new skills, or hobbies
- Social engagement and maintaining relationships to support brain health
- Managing cardiovascular risk factors like blood pressure, cholesterol, and blood sugar
- Quality sleep of seven to nine hours per night
- Stress reduction through meditation, yoga, or other relaxation techniques
- Limiting alcohol and avoiding smoking
- Treatment of underlying conditions like depression, sleep apnea, or hearing loss
- Regular follow-up with healthcare providers to monitor cognitive changes
No medications are specifically approved for MCI, but your doctor may treat underlying conditions that contribute to cognitive decline. Some people with MCI may be candidates for clinical trials testing new treatments. Work with your healthcare team to create a personalized plan based on your risk factors and genetic profile.
Need testing for Mild Cognitive Impairment (MCI)? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Normal aging may include occasional forgetfulness, like misplacing keys or forgetting a name temporarily. MCI involves more noticeable memory or thinking changes that go beyond typical age-related decline. The key difference is that MCI is noticeable to you and others, happens more frequently, but does not yet interfere with your ability to live independently or perform daily activities.
No, not everyone with MCI develops dementia. Studies show that about 10 to 15 percent of people with MCI progress to dementia each year. However, some people remain stable for years, and others actually improve. Your individual risk depends on factors like the type of MCI, underlying causes, genetic factors, and lifestyle habits.
The ApoE gene provides instructions for making a protein that helps carry cholesterol and fats in your bloodstream. People who inherit the ε4 variant of this gene have higher risk of developing Alzheimer's disease. If you have MCI and carry the ApoE ε4 variant, you have increased risk of progression to Alzheimer's dementia compared to those without this genetic variant.
ApoE genotype testing is done through a simple blood draw. The lab analyzes your DNA to determine which variants of the ApoE gene you inherited from your parents. You can have ε2, ε3, or ε4 variants. Rite Aid offers this genetic test as an add-on to help you understand your risk and make informed decisions about monitoring and prevention.
Yes, research shows that lifestyle changes can make a meaningful difference. Regular exercise, a healthy diet, mental stimulation, social engagement, and managing cardiovascular risk factors have all been linked to slower cognitive decline. While lifestyle changes cannot guarantee prevention, they offer your best opportunity to influence your brain health trajectory.
Most doctors recommend follow-up evaluations every six to 12 months for people with MCI. These visits typically include cognitive testing to track any changes in memory or thinking skills. Your doctor may adjust the monitoring schedule based on your symptoms, risk factors, and test results. Regular monitoring helps catch any progression early.
Yes, MCI is classified into two main types. Amnestic MCI primarily affects memory and has stronger links to Alzheimer's disease. Non-amnestic MCI mainly affects thinking skills other than memory, like language, attention, or visual-spatial abilities. Each type may have different causes and different risks for progression to specific forms of dementia.
Talk to your doctor as soon as you notice persistent memory or thinking changes. Early evaluation can identify treatable causes like medication side effects, vitamin deficiencies, or thyroid problems. If MCI is diagnosed, early intervention with lifestyle changes and risk factor management offers the best chance to slow progression. Do not dismiss symptoms as just normal aging.
Currently, no medications are specifically approved to treat MCI. Some doctors may prescribe medications used for Alzheimer's disease, but evidence for their benefit in MCI is limited. The focus is typically on treating underlying conditions that contribute to cognitive decline, like high blood pressure or diabetes. Clinical trials are testing new treatments that may help in the future.
ApoE testing is a personal decision to discuss with your doctor. The results can provide information about your risk of progression to Alzheimer's disease and help guide monitoring and prevention strategies. However, the test does not diagnose MCI or predict with certainty whether you will develop dementia. Some people prefer to know their genetic risk, while others do not find the information helpful.